Filter
312
Text search:
Wellcome
Trust
Featured
Recommendations
27
New Publications
63
Language
Document type
No document type
125
Studies & Reports
101
Guidelines
30
Infographics
17
Manuals
13
Strategic & Response Plan
10
Fact sheets
8
Situation Updates
3
Training Material
2
Brochures
1
Resource Platforms
1
Videos
1
Countries / Regions
Global
22
Kenya
17
Africa
14
Malawi
10
India
8
South Africa
6
Brazil
6
Latin America and the Carribbean
5
Senegal
4
Congo, Democratic Republic of
4
Uganda
4
Ukraine
4
Guinea
3
Rwanda
3
Sierra Leone
2
Nigeria
2
Ethiopia
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Russia
2
Belarus
2
Ghana
1
Zimbabwe
1
Philippines
1
Pakistan
1
South Sudan
1
Lebanon
1
Syria
1
Tanzania
1
Cambodia
1
Bangladesh
1
Mozambique
1
Sudan
1
Peru
1
Ecuador
1
East and Southern Africa
1
South–East Asia Region
1
Western and Central Europe
1
Asia
1
Laos
1
Tajikistan
1
Qatar
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
67
Clinical Guidelines
31
Public Health
19
Women & Child Health
9
Key Resources
6
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
47
Mental Health
33
Planetary Health
27
AMR
24
HIV
20
Ebola
18
TB
18
NTDs
16
Global Health Education
13
Rapid Response
12
Health Financing Toolbox
10
NCDs
9
Disability
6
Zika
6
Caregiver
6
Pharmacy
3
Cholera
2
Conflict
2
Polio
1
Natural Hazards
1
Refugee
1
Social Ethics
1
Expanding access to quality health services through task sharing
Technical Document
Implementation guide for national, district and facility levels.
This implementation guide contains practical guidance for policy-makers,
programme managers, health practitioners and other actors working to
establish and implement quality of care (QoC) programmes for maternal,
newborn and child
...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a
...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s
...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t
...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b
...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e
...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers
...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought
...
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how a
...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant
...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
A global Pandemic, Preparedness and Response (RRR) architecture
